A rational approach to dose optimisation of pembrolizumab and nivolumab using cost analysis and pharmacokinetic modelling and simulation.
Affiliation
Centre for Applied Pharmacokinetic Research, The University of Manchester, Manchester,Issue Date
2016-10-01
Metadata
Show full item recordCitation
A rational approach to dose optimisation of pembrolizumab and nivolumab using cost analysis and pharmacokinetic modelling and simulation. 2016, 27(suppl_6):1082P Annals of OncologyJournal
Annals of OncologyDOI
10.1093/annonc/mdw378.36Additional Links
https://academic.oup.com/annonc/article/2799877/AType
Meetings and ProceedingsLanguage
enISSN
0923-75341569-8041
ae974a485f413a2113503eed53cd6c53
10.1093/annonc/mdw378.36